Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism

Nephrol Dial Transplant. 2022 Mar 25;37(4):792-795. doi: 10.1093/ndt/gfab353.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism
  • Humans
  • Hyperparathyroidism, Secondary* / drug therapy
  • Hyperparathyroidism, Secondary* / etiology
  • Hyperparathyroidism, Secondary* / metabolism
  • Parathyroid Hormone / metabolism
  • Pharmacogenetics
  • Receptors, Calcitriol* / genetics
  • Receptors, Calcitriol* / metabolism
  • Renal Dialysis
  • Vitamin D
  • Vitamin D-Binding Protein / genetics
  • Vitamin D-Binding Protein / metabolism

Substances

  • Parathyroid Hormone
  • Receptors, Calcitriol
  • Vitamin D-Binding Protein
  • Vitamin D
  • Calcium